Avantax Advisory Services’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $5.34M | Buy |
49,719
+7,103
| +17% | +$763K | 0.03% | 433 |
|
2025
Q1 | $4.3M | Buy |
42,616
+6,200
| +17% | +$625K | 0.03% | 464 |
|
2024
Q4 | $3.25M | Buy |
36,416
+7,282
| +25% | +$650K | 0.02% | 531 |
|
2024
Q3 | $2.44M | Sell |
29,134
-3,714
| -11% | -$311K | 0.02% | 608 |
|
2024
Q2 | $2.53M | Buy |
32,848
+17,583
| +115% | +$1.35M | 0.02% | 580 |
|
2024
Q1 | $1.05M | Buy |
15,265
+129
| +0.9% | +$8.84K | 0.01% | 728 |
|
2023
Q4 | $875K | Sell |
15,136
-830
| -5% | -$48K | 0.01% | 762 |
|
2023
Q3 | $843K | Sell |
15,966
-3,797
| -19% | -$200K | 0.01% | 749 |
|
2023
Q2 | $1.07M | Buy |
19,763
+1,201
| +6% | +$65K | 0.01% | 657 |
|
2023
Q1 | $929K | Buy |
18,562
+118
| +0.6% | +$5.9K | 0.01% | 684 |
|
2022
Q4 | $853K | Buy |
18,444
+2,803
| +18% | +$130K | 0.01% | 682 |
|
2022
Q3 | $606K | Buy |
15,641
+2,490
| +19% | +$96.5K | 0.01% | 699 |
|
2022
Q2 | $490K | Buy |
13,151
+323
| +3% | +$12K | 0.01% | 789 |
|
2022
Q1 | $567K | Sell |
12,828
-1,949
| -13% | -$86.1K | 0.01% | 741 |
|
2021
Q4 | $628K | Buy |
14,777
+31
| +0.2% | +$1.32K | 0.01% | 682 |
|
2021
Q3 | $645K | Buy |
14,746
+722
| +5% | +$31.6K | 0.01% | 622 |
|
2021
Q2 | $601K | Buy |
14,024
+196
| +1% | +$8.4K | 0.01% | 635 |
|
2021
Q1 | $538K | Buy |
13,828
+371
| +3% | +$14.4K | 0.01% | 597 |
|
2020
Q4 | $484K | Sell |
13,457
-3,437
| -20% | -$124K | 0.01% | 565 |
|
2020
Q3 | $649K | Buy |
16,894
+2,454
| +17% | +$94.3K | 0.01% | 705 |
|
2020
Q2 | $508K | Buy |
14,440
+1,929
| +15% | +$67.9K | 0.01% | 479 |
|
2020
Q1 | $411K | Buy |
12,511
+5,638
| +82% | +$185K | 0.01% | 485 |
|
2019
Q4 | $312K | Buy |
+6,873
| New | +$312K | 0.01% | 613 |
|
2019
Q3 | – | Sell |
-5,330
| Closed | -$229K | – | 573 |
|
2019
Q2 | $229K | Buy |
+5,330
| New | +$229K | 0.01% | 453 |
|